PRF Technologies (PRFX) Change in Cash (2020 - 2024)
PRF Technologies (PRFX) posted quarterly Change in Cash of $3.9 million for Q2 2024, up 229.7% year-on-year from $1.2 million in Q3 2023, and up 205.21% on a QoQ basis from -$3.7 million in Q1 2024.
PRF Technologies (PRFX) Change in Cash (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has reported Change in Cash for 5 consecutive years, with $3.9 million the latest figure, recorded in Q2 2024.
- Quarterly Change in Cash rose 229.7% year-over-year to $3.9 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $3.1 million (up 135.33% YoY) and the FY2025 annual result came in at -$1.1 million, up 70.23% from the prior year.
- Change in Cash rose to $3.9 million in Q2 2024 per PRFX's latest filing, from -$3.7 million in the prior quarter.
- Over the last five years, Change in Cash for PRFX reached as high as $2.7 billion in Q3 2021 and fell as low as -$2.7 billion in Q4 2021.
- A 5-year average of $404555.6 and a median of -$671000.0 in 2020 frame the typical range for Change in Cash.
- The largest YoY upside for Change in Cash was 15493.58% in 2021 against a maximum downside of 131681.55% in 2021.
- Year by year, Change in Cash stood at -$2.0 million in 2020, then plunged by 131681.55% to -$2.7 billion in 2021, then surged by 99.89% to -$2.8 million in 2022, then soared by 116.76% to $476000.0 in 2023, then surged by 718.28% to $3.9 million in 2024.
- According to Business Quant data, Change in Cash over the past three periods registered $3.9 million, -$3.7 million, and $476000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | 476,000.00 |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -1.58 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -2.68 Bn |
| Sep 30, 2021 | 2.68 Bn |
| Jun 30, 2021 | -1.63 Mn |
| Mar 31, 2021 | 3.75 Mn |
| Dec 31, 2020 | -2.03 Mn |
| Sep 30, 2020 | 17.17 Mn |
| Jun 30, 2020 | -182,000.00 |
| Mar 31, 2020 | -215,000.00 |